Article
Brain shuttle target expression levels vary by individual, not by brain region, disease, age, or sex
2026-05-23
Abstract excerpt
Therapeutics fused to brain shuttles that exploit endogenous receptor-mediated transport at the blood–brain barrier (BBB) offer a promising strategy to deliver large molecule drugs and biologics to the CNS. A fundamental but untested assumption underlying their clinical development is that their endothelial receptor targets are consistently expressed between individuals and between patient populations. Here, we an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d51bca00-42f9-5d08-8c72-74ecb670b8cb
- DOI
- 10.64898/2026.05.21.726908
